New AI transforms radiology with speed, accuracy never seen before. Northwestern University. Journal JAMA Network Open DOI 10.1001/jamanetworkopen.2025.13921 ...

Risankizumab (Skyrizi), a selective anti-interleukin-23 (IL-23) biologic agent, is increasingly used in the treatment of Crohn's disease (CD). A previous head-to-head study has demonstrated its ...

aga reading room Joanna Melia, MD, on Boosting Treatment Responses in Refactory IBD Rahul S. Dalal, MD, MPH, on the Benefits of Risankizumab Dose Intensification in CD ...